Beckman Coulter has been a global leader in advanced diagnostics for more than 80 years, and with the dawn of software as a diagnostic tool, we are still relentlessly reimagining healthcare. With the recent acquisition of the TriageGO tool and launch of the CDS Business Unit, we've established our commitment to the development of machine learning and artificial intelligence as it applies to diagnostics. Beckman Coulter is committed to innovating AI technologies that improve clinical decision making for years to come.